Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.53 |
| ▸ | ACHE | P22303 | 2/20 | 0.50 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | CNR2 | P34972 | 1/20 | 0.46 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.46 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.46 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | TEAD4 | Q15561 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8364605 | 0.93 | KMT2A (0.49) | ALDH1A3KMT2AMAPTALDH1A1NLRP1 | |
| SCHEMBL125543 | 0.88 | ALDH1A3 (0.64) | ALDH1A3KMT2AALDH1A1PARP10POLB | |
| SCHEMBL16406583 | 0.87 | MAPT (0.45) | ALDH1A3KMT2AMAPTALDH1A1NLRP1 | |
| SCHEMBL10047613 | 0.87 | MAPT (0.45) | ALDH1A3KMT2AMAPTALDH1A1NLRP1 | |
| SCHEMBL1162019 | 0.83 | ACHE (0.50) | ALDH1A3KMT2AMAPTALDH1A1NLRP1 | |
| SCHEMBL18997928 | 0.83 | KMT2A (0.63) | KMT2AMAPTALDH1A1NLRP1PARP10 | |
| SCHEMBL21558858 | 0.83 | MAPT (0.46) | ALDH1A3KMT2AMAPTALDH1A1NLRP1 | |
| Hydrogen Peroxide SCHEMBL28902806 | 0.82 | KMT2A (0.70) | ALDH1A3KMT2AALDH1A1PARP10POLB | |
| SCHEMBL23128645 | 0.82 | MAOB (0.56) | KMT2AMAPTALDH1A1NLRP1PARP10 | |
| SCHEMBL9102528 | 0.82 | KMT2A (0.85) | KMT2AMAPTALDH1A1NLRP1PARP10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 940 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114854489-B | Chamomile essential oil and preparation method and application thereof | 北京市农林科学院 | 2024-03-22 | — | — | CN | claimed |
| EP-4277591-A1 | ETHER COMPOUNDS AS VOLATILES FOR THE TREATMENT OF AMINO ACID BASED SUBSTRATES, SUCH AS SKIN AND HAIR | Momentive Performance Materials GmbH (DE) | 2023-11-22 | — | — | EP | claimed |
| CN-114854489-A | Essential oil of Mao Huaju, preparation method and application thereof | 北京市农林科学院 | 2022-08-05 | — | — | CN | claimed |
| WO-2022152742-A1 | ETHER COMPOUNDS AS VOLATILES FOR THE TREATMENT OF AMINO ACID BASED SUBSTRATES, SUCH AS SKIN AND HAIR | MOMENTIVE PERFORMANCE MATERIALS GMBH (DE) | 2022-07-21 | — | — | WO | claimed |
| EP-3112352-A1 | OPIOID RECEPTOR MODULATORS | Janssen Pharmaceutica NV (BE) | 2017-01-04 | — | — | EP | claimed |
| US-8088797-B2 | Substituted N-(4-cyano-1H-pyrazol-3-yl)methylamine derivatives, preparation thereof and therapeutic use thereof | SANOFI-AVENTIS (FR) | 2012-01-03 | — | — | US | claimed |
| EP-1725537-B1 | NOVEL COMPOUNDS AS OPIOID RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2011-07-13 | — | — | EP | claimed |
| US-20100041709-A1 | SUBSTITUTED N-(4-CYANO-1H-PYRAZOL-3-YL)METHYLAMINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF | SANOFI-AVENTIS (FR) | 2010-02-18 | — | — | US | claimed |
| US-20090171046-A1 | PROCESS FOR PRODUCING POLYDIENES | BRIDGESTONE CORPORATION (JP) | 2009-07-02 | — | — | US | claimed |
| EP-2075267-A2 | Process for producing polydienes | Bridgestone Corporation (JP) | 2009-07-01 | — | — | EP | claimed |
| US-4533766-A | Process for the production of dihydroxybenzenes | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1985-08-06 | — | — | US | claimed |
| US-4029690-A | WITH 2,5-DIMETHYL-2,4-HEXADIENE AND AN ALKYL DIAZOACETATE WITH A COPPER COMPLEX CATALYST | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-06-14 | — | — | US | claimed |
| US-4029683-A | WITH A SCHIFF BASE, CHRYSANTHEMATE SYNTHESIS CATALYST | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-06-14 | — | — | US | claimed |
| US-20260124192-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS OF TREATING RNA VIRAL INFECTIONS | MODEL MEDICINES INC (US) | 2026-05-07 | — | — | US | disclosed |
| US-RE50030-E1 | Methods to treat lymphoplasmacytic lymphoma | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2024-07-02 | — | — | US | disclosed |
| WO-2024115641-A1 | NONCOVALENT KEAP1-NRF2 SMALL-MOLECULE INHIBITORS | UNIVERSITY OF COPENHAGEN (DK) | 2024-06-06 | — | — | WO | disclosed |
| EP-0012240-A2 | Process for manufacturing of optionally substituted benzaldehyd-dialkyl acetals | BAYER AG (DE) | 1980-06-25 | — | — | EP | disclosed |
| US-4174460-A | Process for the hydroxylation of phenols and phenol ethers in the nucleus | BAYER AKTIENGESELLSCHAFT (DE) | 1979-11-13 | — | — | US | disclosed |
| US-4113782-A | CATALYTIC OXIDATION | AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 1978-09-12 | — | — | US | disclosed |
| US-4045496-A | Process for the hydroxylation of phenols and phenol ethers in the nucleus | BAYER AKTIENGESELLSCHAFT (DT) | 1977-08-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260124192-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS OF TREATING RNA VIRAL INFECTIONS | SARS1, NSUN2, NSUN3 | ALDH1A3 2622/4885KMT2A 1708/4885MAPT 153/4885 |
| US-20100041709-A1 | SUBSTITUTED N-(4-CYANO-1H-PYRAZOL-3-YL)METHYLAMINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF | PRMT3, PRMT5, PRMT1 | ALDH1A3 1467/4885KMT2A 1197/4885MAPT 3121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.